US2004180105A1PendingUtilityA1
Use of extracts of ginkgo biloba for preparing a medicament
Assignee: CONSEILS DE RECH S D APPLIC SCPriority: Dec 3, 1997Filed: Mar 25, 2004Published: Sep 16, 2004
Est. expiryDec 3, 2017(expired)· nominal 20-yr term from priority
Inventors:Katy Drieu
A61P 25/30A61K 36/16A61P 25/36A61P 25/34A61P 25/20A61P 25/32
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the use of Ginkgo biloba extracts for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of a substance engendering dependency and/or addiction, such as in particular alcohol, amphetamines, tobacco, drugs inducing toxicomania.
Claims
exact text as granted — not AI-modified1 . Use of a Ginkgo biloba extract for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of a substance engendering dependency and/or addiction, such as in particular alcohol, amphetamines, tobacco, drugs inducing toxicomania.
2 . Use according to claim 1 , characterized in that the Ginkgo biloba extract is an extract of type EGb 761.
3 . Use according to claim 1 , characterized in that the Ginkgo biloba extract is an extract of type CP 401.
4 . Use according to claim 1 , characterized in that the Ginkgo biloba extract contains at least 5% of ginkgolides.
5 . Use according to claim 4 , characterized in that the Ginkgo biloba extract contains at least 50% of ginkgolides.
6 . Use of a compound of general formula (I)
in which w, x, y and z independently represent the H, OH, linear or branched alkoxy or O-G S radicals, G S -OH representing a mono- or a disaccharide, or one of their derivatives or analogues,
it being understood that at least one of W, X, Y or Z represents an O-G S radical,
for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of a substance engendering dependency and/or addiction, such as in particular alcohol, amphetamines, tobacco, drugs inducing toxicomania.
7 . Use according to claim 6 , characterized in that:
either W represents an OH or O-G S radical, Y represents H and Z represents H; or W represents an OH or O-G S radical, Y represents an OH or O-G S radical and Z represents H; or W represents an OH or O-G S radical, Y represents an OH or O-G S radical and Z represents an OH or O-G S radical; or W represents an OH or O-G S radical, Y represents H and Z represents an OH or O-G S radical; or W represents H, Y represents an OH or O-G S radical and Z represents an OH or O-Gs radical; or W represents an OH or O-G S radical, Y represents a linear or branched alkoxy radical and Z represents H; it being understood that at least one of W, X, Y or Z represents an O-G S . radical
8 . Use according to claim 6 or 7 , characterized in that:
either W represents an OH or O-G S radical, Y represents H and Z represents H;
or W represents an OH or O-G S radical, Y represents an OH or O-G S radical and Z represents H;
or W represents an OH or O-G S radical, Y represents a linear or branched alkoxy radical and Z represents H;
it being understood that at least one of W, X, Y or Z represents an O-G S . radical
9 . Use of a ginkgolide or one of its glycosylated, alkoxylated or acetylated derivatives, or of a pharmaceutically active salt of the latter for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of a substance engendering habituation and/or addiction, such as in particular alcohol, amphetamines, tobacco, drugs inducing toxicomania.
10 . Use according to claim 9 , characterized in that the ginkgolide is ginkgolide A or ginkgolide B.Join the waitlist — get patent alerts
Track US2004180105A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.